Chemotherapy and Targeted Therapy

Scaling Solubility: AustinPx and Thermo Fisher Scientific Forge Strategic Alliance to Revolutionize Amorphous Solid Dispersions

• Chemotherapy and Targeted Therapy

Scaling Solubility: AustinPx and Thermo Fisher Scientific Forge Strategic Alliance to Revolutionize Amorphous Solid Dispersions

Laily UPN July 10, 2026

In a move set to redefine the landscape of small-molecule drug development, AustinPx, a Texas-based contract development...

Read More Read more about Scaling Solubility: AustinPx and Thermo Fisher Scientific Forge Strategic Alliance to Revolutionize Amorphous Solid Dispersions

Clinical Setback: Eplontersen Fails Key Phase 3 Trial, Reshaping the ATTR-CM Competitive Landscape

• Chemotherapy and Targeted Therapy

Clinical Setback: Eplontersen Fails Key Phase 3 Trial, Reshaping the ATTR-CM Competitive Landscape

Iffa Jayyana July 9, 2026

By [Author Name/Staff Reporter] Published July 9, 2026 In a stunning development that has sent shockwaves through...

Read More Read more about Clinical Setback: Eplontersen Fails Key Phase 3 Trial, Reshaping the ATTR-CM Competitive Landscape

Operation Trialblazer: Can a Regulatory Overhaul Restore U.S. Dominance in Drug Development?

• Chemotherapy and Targeted Therapy

Operation Trialblazer: Can a Regulatory Overhaul Restore U.S. Dominance in Drug Development?

Muslim July 9, 2026

The American pharmaceutical landscape is currently grappling with a dual crisis: a surge in the complexity of...

Read More Read more about Operation Trialblazer: Can a Regulatory Overhaul Restore U.S. Dominance in Drug Development?

Beyond the Psychedelic Hype: Are We Witnessing the "Prozac Moment" of the 2020s?

• Chemotherapy and Targeted Therapy

Beyond the Psychedelic Hype: Are We Witnessing the "Prozac Moment" of the 2020s?

Laily UPN July 9, 2026

For years, the narrative surrounding classic psychedelics like psilocybin has been one of radical transformation. From the...

Read More Read more about Beyond the Psychedelic Hype: Are We Witnessing the "Prozac Moment" of the 2020s?

The New Frontier in Nephrology: Vera Therapeutics’ Trutakna Enters the IgA Nephropathy Battleground

• Chemotherapy and Targeted Therapy

The New Frontier in Nephrology: Vera Therapeutics’ Trutakna Enters the IgA Nephropathy Battleground

Nana July 9, 2026

By: Editorial Desk Date: July 7, 2026 The landscape of nephrology underwent a significant transformation this week...

Read More Read more about The New Frontier in Nephrology: Vera Therapeutics’ Trutakna Enters the IgA Nephropathy Battleground

From Data Repository to Clinical Engine: How ConcertAI is Rewriting the Oncology Playbook

• Chemotherapy and Targeted Therapy

From Data Repository to Clinical Engine: How ConcertAI is Rewriting the Oncology Playbook

Laily UPN July 9, 2026

In the complex, high-stakes world of modern oncology, the gap between cutting-edge clinical research and day-to-day patient...

Read More Read more about From Data Repository to Clinical Engine: How ConcertAI is Rewriting the Oncology Playbook

British Pharma Giants Double Down on China Amid Growing Regulatory Scrutiny

• Chemotherapy and Targeted Therapy

British Pharma Giants Double Down on China Amid Growing Regulatory Scrutiny

Nana Muazin July 8, 2026

By Jonathan Gardner | Published July 8, 2026 In a strategic maneuver that highlights the persistent allure...

Read More Read more about British Pharma Giants Double Down on China Amid Growing Regulatory Scrutiny

The Silent Crisis: Why the Biopharma Industry is Bleeding Critical Process Knowledge

• Chemotherapy and Targeted Therapy

The Silent Crisis: Why the Biopharma Industry is Bleeding Critical Process Knowledge

Nana Muazin July 8, 2026

In the high-stakes world of biopharmaceutical manufacturing, the adage "knowledge is power" is more than a cliché—it...

Read More Read more about The Silent Crisis: Why the Biopharma Industry is Bleeding Critical Process Knowledge

Vertex Pharmaceuticals Executes $10 Billion Strategic Acquisition of Crinetics to Anchor Future Growth

• Chemotherapy and Targeted Therapy

Vertex Pharmaceuticals Executes $10 Billion Strategic Acquisition of Crinetics to Anchor Future Growth

Iffa Jayyana July 8, 2026

In a landmark move that signals a decisive shift in its long-term corporate strategy, Vertex Pharmaceuticals announced...

Read More Read more about Vertex Pharmaceuticals Executes $10 Billion Strategic Acquisition of Crinetics to Anchor Future Growth

From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development

• Chemotherapy and Targeted Therapy

From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development

Siti Muinah July 8, 2026

The landscape of metabolic medicine is undergoing a seismic transformation. For nearly two decades, the treatment of...

Read More Read more about From Pens to Pills: The Scientific Paradigm Shift in GLP-1 Drug Development